Lv1
90 积分 2025-10-22 加入
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
15天前
已完结
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
15天前
已完结
Lessons Learned from Targeting IGF-I Receptor in Thyroid-Associated Ophthalmopathy
1个月前
已完结
Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention study
1个月前
已关闭
Clinicogenomic landscape and function of PIK3CA , AKT1 , and PTEN mutations in breast cancer
1个月前
已完结
Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study
2个月前
已完结
POS0230 DISAGREEMENT BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OVER TIME IN PSORIATIC ARTHRITIS: INSIGHT INTO TREATMENT PRIORITIES
4个月前
已完结
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial
4个月前
已完结
Akt inhibitors in clinical development for the treatment of cancer
4个月前
已完结
Signalling specificity in the Akt pathway in breast cancer
4个月前
已完结
皖公网安备34019202002308
